Helicos BioSciences Corporation [HLCS]- 07/02/2007

Stanley N. Lapidus, President and CEO of Helicos BioSciences Corporation, presides over the closing bell.

Monday July 2, 2007
from Nasdaq MarketSite
in New York's Times Square

Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote

Stanley N. Lapidus, President and CEO of Helicos BioSciences Corporation (HLCS), presides over the closing bell.

Helicos BioSciences Corporation is a life sciences company developing innovative genetic analysis technologies for the research, drug discovery and clinical diagnostics markets. The company has developed its proprietary True Single Molecule Sequencing technology to enable ultra-high-throughput genetic analysis based on the direct sequencing of single molecules of nucleic acids. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800.

Reprints

Click for larger pictures of the NASDAQ MarketSite.

Additional Photographs for 07/02/2007

Download Hi-Res Quality Photo of this NASDAQ Market Open
- Pictured: Stanley N. Lapidus, President and CEO of Helicos BioSciences Corporation, presides over the closing bell.
Organizations interested in obtaining NASDAQ-listed company bell ringing ceremony photographs for press purposes, must first receive approval from the listed company before requesting photographs from NASDAQ. Please provide the company contact information from whom you received approval to Jolene Libretto at Jolene.Libretto@nasdaq.com. Kindly credit © 2007, The Nasdaq Stock Market, Inc. Reprinted with permission.